Verification evidence is still being completed.
PDF / print export
Recipharm
Stockholm, Sweden
- Verified lead
- Greg Behar
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply
- Review cycle
- May 2026
- Full address
- Klara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Recipharm leadership page confirming Greg Behar as CEO.
- Editorial note
- Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply
GMP pharmaceutical manufacturing network, Quality and supply-chain operations
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated07 Jul 2026, 01:10
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
Contact & location
- Website
- recipharm.com
- Company page
- Lead
- Greg Behar (verified ↗)
- Compliance
- GMP pharmaceutical manufacturing network
- Last reviewed
- 14 Mar 2026 (4mo ago)
- Scale
- International CDMO manufacturing
- Capabilities
- Sterile Manufacturing · Finished Dose Production · CDMO Supply Operations
- Founded
- 1995
- Headcount
- 5001-10000
CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
Related companies
Editorial note
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Verification details
Clinical profileSTATUS: VERIFIED MARCH 2026
Greg Behar
Chief Executive Officer
Full addressKlara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Recipharm Stockholm city HQ page listing the visiting address at Klara Ostra Kyrkogata 6.
Open sourceInternational CDMO manufacturing
Stockholm, Sweden. CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply. Review completed on 14 Mar 2026.
EU and global pharmaceutical manufacturing oversight
GMP pharmaceutical manufacturing network, Quality and supply-chain operations
Capabilities
Sterile Manufacturing
Finished Dose Production
CDMO Supply Operations
Sources
The official sources used to verify this profile.
Infrastructure
Sterile manufacturing lines
Finished-dose production suites
Global quality systems
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
Frequently asked questions
- Where is Recipharm located?
- Recipharm operates from Klara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden, Stockholm, Sweden.
- Who runs Recipharm?
- Recipharm is led by Greg Behar, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Recipharm hold?
- Recipharm is documented under GMP pharmaceutical manufacturing network.
- What does Recipharm do?
- Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint. Core capabilities: Sterile Manufacturing, Finished Dose Production, CDMO Supply Operations.
Editorial context
Related technical briefs
Briefs that name Stockholm as a covered market or city.